Cancer BiologybioRxivPreprint
Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma
Alexander Grenander Raufi, Ilenia Pellicciotta, Carmine F. Palermo…·Gulam Abbas Manji
This study shows that combining gemcitabine with CXCR4 inhibitors and anti-PD1 therapy improves immune response and survival in pancreatic cancer models.